Chard Daniel R
SEC Form 4 insider trading activity
Chard Daniel R has filed 2 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Oct 1, 2026.
On the most recent filing, Chard Daniel R is listed as Director at MEDIFAST INC. Inside the rolling window, Chard Daniel R reported 1 open-market purchase totaling $179K in MED and 2 open-market sales totaling $226K in MED. The largest disclosed transaction in the window is a purchase of 17,678 MED shares on Mar 20, 2026, worth $179K.
Companies traded
Other insiders at MED
Insider Buying
$179K
reported purchases (SEC code P)
Insider Selling
$226K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Chard Daniel R made?
Chard Daniel R has filed 2 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.
Which companies does Chard Daniel R trade?
Chard Daniel R has filed SEC Form 4 disclosures for 1 company, including MED.
When was Chard Daniel R's most recent SEC Form 4 filing?
Chard Daniel R's most recent SEC Form 4 filing on Tracefour is dated Oct 1, 2026.
What is Chard Daniel R's total buy and sell value in the current window?
Inside the rolling retention window, Chard Daniel R bought $179K and sold $226K based on SEC Form 4 filings.
What was Chard Daniel R's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 17,678 MED shares on 2026-03-20, worth $179K, per SEC Form 4 filings.